Women with estrogen positive breast cancer who have radiation therapy on top of their hormone therapy increase disease-free survival and improve the odds a cancer won't come back over the long term significantly
Research from the Paracelsus Medical University in Salzburg, Austria shows that where women with breast cancer had hormone treatment plus radiotherapy, the cancer did not come back in the same breast across the ten year study period in 97.5% of cases. Where they had hormone therapy alone, this figure fell to 92%.
This 5.64% drop across the large numbers of women who are diagnosed with ER+ve breast cancer would be hugely significant.Of course, some women see their breast cancer move to the other breast. Dr. Gerd Fastner, author of the study confirmed that where the cancer did go to the other breast, 94.5% of women who had radiotherapy were still alive after the 10 year study period, against 88% who did not have radiotherapy. The combination therapy continues to perform much better than hormone therapy alone.
The research involved 900 post-menopausal women, all of whom had had a lumpectomy rather than a mastectomy. All had hormonally-driven cancers. The study was funded by Astra Zeneca.
Go Here to Buy Book at Cheapest Price Online
CANCERactive – empowering you with science-based medicine